Cryoport (CYRX) EBIAT (2016 - 2025)
Cryoport (CYRX) has disclosed EBIAT for 14 consecutive years, with -$8.2 million as the latest value for Q4 2025.
- On a quarterly basis, EBIAT rose 4.95% to -$8.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $78.3 million, a 174.78% increase, with the full-year FY2025 number at $78.3 million, up 174.78% from a year prior.
- EBIAT was -$8.2 million for Q4 2025 at Cryoport, down from -$6.7 million in the prior quarter.
- In the past five years, EBIAT ranged from a high of $105.2 million in Q2 2025 to a low of -$260.1 million in Q4 2021.
- A 5-year average of -$21.9 million and a median of -$8.9 million in 2022 define the central range for EBIAT.
- Peak YoY movement for EBIAT: tumbled 2155.93% in 2021, then skyrocketed 234.87% in 2025.
- Cryoport's EBIAT stood at -$260.1 million in 2021, then surged by 96.37% to -$9.4 million in 2022, then tumbled by 561.18% to -$62.4 million in 2023, then surged by 86.17% to -$8.6 million in 2024, then increased by 4.95% to -$8.2 million in 2025.
- Per Business Quant, the three most recent readings for CYRX's EBIAT are -$8.2 million (Q4 2025), -$6.7 million (Q3 2025), and $105.2 million (Q2 2025).